Literature DB >> 7234871

Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome).

K J Lips, J Van der Sluys Veer, A Struyvenberg, A Alleman, J R Leo, P Wittebol, W H Minder, C J Kooiker, R A Geerdink, P F Van Waes, W H Hackeng.   

Abstract

Two kindreds with the multiple endocrine neoplasia type 2A syndrome were studied. Of one of these we examined 150 members, 20 of whom were treated with thyroidectomy for medullary carcinoma and nine with bilateral adrenalectomy for pheochromocytoma. Of the second kindred 50 members were examined, seven of whom were thyroidectomized and seven treated with bilateral adrenalectomy. Pheochromocytomas were invariably found on both sides, even in four cases in which the adrenals on one side appeared to be completely normal, not only at preoperative roentgenologic examination but also on inspection during the operation. The microscopic finding of micronodules and a cluster of abnormal medullary cells identical with those found in pheochromocytomas in one of the apparently normal adrenals represents a first stage in the development of diffuse medullary hyperplasia as well as nodular hyperplasia. This is in accordance with the fact that in the MEN type 2A syndrome pheochromocytomas are always multicentric and multiple in origin. On the basis of these findings we conclude that all patients with the MEN 2A syndrome who show symptoms and signs of active pheochromocytoma should be subjected to bilateral adrenalectomy, even when one or both of the adrenals appear to be normal at roentgenologic investigation.

Entities:  

Mesh:

Year:  1981        PMID: 7234871     DOI: 10.1016/0002-9343(81)90866-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  Pheochromocytoma.

Authors:  P E Cryer
Journal:  West J Med       Date:  1992-04

2.  Prevalence of C-cell hyperplasia and medullary thyroid carcinoma in a consecutive series of pheochromocytoma patients.

Authors:  S Jansson; G Hansson; H Salander; G Stenström; L E Tisell
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

3.  Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome.

Authors:  J A van Heerden; G W Sizemore; J A Carney; C S Grant; W H ReMine; S G Sheps
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

4.  Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA.

Authors:  S Tibblin; J F Dymling; S Ingemansson; M Telenius-Berg
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

5.  Adrenalectomy for familial pheochromocytoma in the laparoscopic era.

Authors:  L Michael Brunt; Terry C Lairmore; Gerard M Doherty; Mary A Quasebarth; Mary DeBenedetti; Jeffrey F Moley
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

6.  Pentagastrin stimulation of calcitonin in pheochromocytoma does not always indicate multiple endocrine neoplasia type II.

Authors:  M D Hein; J M Monchik; I M Jackson
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

7.  The clinical implications of a positive calcitonin test for C-cell hyperplasia in genetically unaffected members of an MEN2A kindred.

Authors:  R M Landsvater; A G Rombouts; G J te Meerman; J M Schillhorn-van Veen; M J Berends; R A Geerdink; A Struyvenberg; C H Buys; C J Lips
Journal:  Am J Hum Genet       Date:  1993-02       Impact factor: 11.025

8.  Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes.

Authors:  T C Lairmore; D W Ball; S B Baylin; S A Wells
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

9.  Bilateral pheochromocytomas.

Authors:  V Kalff; B Shapiro; R Lloyd; M Nakajo; J C Sisson; W H Beierwaltes
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

10.  Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Authors:  Christian A Koch; David Mauro; McClellan M Walther; W Marston Linehan; Alexander O Vortmeyer; Ronald Jaffe; Karel Pacak; George P Chrousos; Zhengping Zhuang; Irina A Lubensky
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.